Justin Dye - 23 Nov 2022 Form 4 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Daniel R. Pabon, Attorney-in-Fact for Justin Dye
Issuer symbol: SHWZ
Transactions as of: 23 Nov 2022
Transactions value $: $1,019,400
Form type: 4
Filing time: 25 Nov 2022, 17:13:50 UTC
Previous filing: 21 Nov 2022
Next filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHWZ	Common Stock	Award	$1,019,400	+509,700	+59%	$2	1,368,062	23 Nov 2022	Direct	F1
holding	SHWZ	Common Stock						9,287,500	23 Nov 2022	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $2.10 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Content

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $2.10 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.